Post-Authorization Safety Studies of Medicinal Products - The PASS Book (Hardcover)


Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions. Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety.

R2,686
List Price R2,886
Save R200 7%

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles26860
Mobicred@R252pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions. Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Academic Press Inc

Country of origin

United States

Release date

June 2018

Availability

Expected to ship within 12 - 17 working days

First published

2018

Editors

,

Dimensions

235 x 191mm (L x W)

Format

Hardcover

Pages

362

ISBN-13

978-0-12-809217-0

Barcode

9780128092170

Categories

LSN

0-12-809217-3



Trending On Loot